MARKET

TTNP

TTNP

Titan Pharma
NASDAQ

Real-time Quotes | Nasdaq Last Sale

0.3340
+0.0840
+33.60%
After Hours: 0.3330 -0.001 -0.30% 19:59 01/17 EST
OPEN
0.2800
PREV CLOSE
0.2500
HIGH
0.3830
LOW
0.2800
VOLUME
96.80M
TURNOVER
--
52 WEEK HIGH
2.450
52 WEEK LOW
0.1420
MARKET CAP
22.24M
P/E (TTM)
-0.2190
1D
5D
1M
3M
1Y
5Y

Buy or sell shares of TTNP and other stocks commission-free!

Open a Webull account and fund it to get a free stock

Analyst Rating

Based on 1 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

EPS

TTNP News

  • Titan Pharmaceuticals Signs Agreement Adding Probuphine Implant To The Federal Supply Schedule
  • Benzinga.01/13 13:14
  • Titan Pharmaceuticals Announces Addition Of Probuphine® To Federal Supply Schedule
  • PR Newswire.01/13 13:00
  • Titan Pharmaceuticals Has Been Awarded A Five Year Veterans Affairs Supply Schedule Contract.
  • Benzinga.01/09 18:40
  • Titan Pharma Filing Shows Registration For $800K Common Stock Offering
  • Benzinga.01/07 21:32

More

Industry

Pharmaceuticals
+0.13%
Pharmaceuticals & Medical Research
+0.06%

Hot Stocks

Name
Price
%Change

About TTNP

Titan Pharmaceuticals, Inc. (Titan) is a specialty pharmaceutical company. The Company is engaged in developing therapeutics for the treatment of medical disorders. The Company's segment is engaged in the development of pharmaceutical products. The Company's product development programs utilize its long-term drug delivery platform, ProNeura. The Company's drug candidate, Probuphine, is being developed for the long-term maintenance treatment of opioid dependence. Titan's ProNeura continuous drug delivery system consists of a small, solid rod made from a mixture of ethylene-vinyl acetate (EVA) and a drug substance. The Company focuses on developing two product development programs, the first one with a ropinirole implant for the treatment of Parkinson's disease (PD) and the second one with a Triiodothyronine (T3) implant for the treatment of hypothyroidism.
More

Webull offers Titan Pharmaceuticals, Inc. (TTNP) stock price, real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, stock news, and many more online research tools to help you make informed decisions.